1.
Xue S-A, Gao L, Thomas S, Hart DP, Xue JZ, Gillmore R, Voss R-H, Morris E, Stauss HJ. Development of a Wilms’ tumor antigen-specific T-cell receptor for clinical trials: engineered patient’s T cells can eliminate autologous leukemia blasts in NOD/SCID mice. Haematologica [Internet]. 2010Jan.11 [cited 2026Nov.17];95(1):126-34. Available from: https://haematologica.org/article/view/5458